Exane BNP Paribas initiated coverage on Elanco Animal Health with a new price target

12/7/23 6:17:43 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Exane BNP Paribas initiated coverage of Elanco Animal Health with a rating of Outperform and set a new price target of $18.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ELAN

Date	Price Target	Rating	Analyst
12/9/2024	$18.00	Buy	UBS
12/2/2024	$14.00	Market Perform	Leerink Partners
9/19/2024	$17.00 → $15.00	Overweight → Equal-Weight	Morgan Stanley
1/5/2024	$13.00 → $20.00	Hold → Buy	Stifel
12/19/2023	$17.00	Buy	Jefferies
12/15/2023	$16.00	Equal-Weight → Overweight	Morgan Stanley
12/7/2023	$18.00	Outperform	Exane BNP Paribas
4/20/2023	$14.00	Equal Weight → Overweight	Barclays